Opus Genetics (IRD) Capital Expenditures Growth (3y) (2013 - 2019)
Opus Genetics (IRD) Capital Expenditures Growth (3y) (2013 - 2019) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
46.88% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Opus Genetics |
355.39 Mn |
295.43 Mn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2019 |
140.66% |
| Jun 30, 2019 |
28.62% |
| Mar 31, 2019 |
42.08% |
| Sep 30, 2018 |
-3.78% |
| Jun 30, 2018 |
-39.77% |
| Mar 31, 2018 |
-31.77% |
| Dec 31, 2017 |
69.26% |
| Sep 30, 2017 |
-39.91% |
| Jun 30, 2017 |
10.12% |
| Mar 31, 2017 |
1.69% |
| Dec 31, 2016 |
-52.20% |
| Sep 30, 2016 |
-74.41% |
| Jun 30, 2016 |
42.85% |
| Mar 31, 2016 |
96.15% |
| Dec 31, 2014 |
-1.57% |
| Sep 30, 2014 |
91.86% |
| Jun 30, 2014 |
69.25% |
| Dec 31, 2013 |
34.93% |
| Sep 30, 2013 |
291.57% |
